- You are viewing a Navigating Care library resource.
- Back to Library
Treatment of Relapsed or Refractory Myelodysplastic Syndromes
For information about the treatments listed below, see the Treatment Option Overview section.
There is no standard treatment for refractory or relapsed myelodysplastic syndromes. Patients whose cancer does not respond to treatment or has come back after treatment may want to take part in a clinical trial.
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
This information is not intended to replace the advice of a doctor.
Navigating Care disclaims any liability for the decisions you make based on this information.
This information was sourced and adapted from Adapted from the National Cancer Institute's
Physician Data Query (PDQ®) Cancer Information Summaries on
www.cancer.gov.
This information updated
November 1, 2024.
Learn more:
- General Information About Myelodysplastic Syndromes
- Treatment Option Overview
- Treatment of Myelodysplastic Syndromes
- Treatment of Relapsed or Refractory Myelodysplastic Syndromes
- To Learn More About Myelodysplastic Syndromes
Related Articles
- General Information About Myelodysplastic Syndromes
- Treatment Option Overview
- Treatment of Myelodysplastic Syndromes
- Treatment of Relapsed or Refractory Myelodysplastic Syndromes
- To Learn More About Myelodysplastic Syndromes
See Expert Resources
The Navigating Care Library includes articles about cancer, chemotherapy regimens and drugs from the
the National Cancer Institute and other experts.
